1. Home
  2. STRO vs LND Comparison

STRO vs LND Comparison

Compare STRO & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$15.13

Market Cap

332.8M

Sector

Health Care

ML Signal

HOLD

Logo Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

LND

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

HOLD

Current Price

$3.70

Market Cap

357.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRO
LND
Founded
2003
2005
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
332.8M
357.6M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
STRO
LND
Price
$15.13
$3.70
Analyst Decision
Strong Buy
Analyst Count
14
0
Target Price
★ $47.23
N/A
AVG Volume (30 Days)
★ 316.2K
49.2K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 3.45%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $38,419,000.00
N/A
Revenue This Year
N/A
$48.42
Revenue Next Year
N/A
$6.82
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.72
$3.37
52 Week High
$43.85
$4.45

Technical Indicators

Market Signals
Indicator
STRO
LND
Relative Strength Index (RSI) 27.32 56.89
Support Level $14.81 $3.70
Resistance Level $17.33 $3.84
Average True Range (ATR) 0.98 0.07
MACD 0.18 -0.00
Stochastic Oscillator 35.49 78.59

Price Performance

Historical Comparison
STRO
LND

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: